Global Health & Biotech Archives | Page 18 of 287 | Be Korea-savvy

Archive by category Global Health & Biotech

Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies

Boehringer Ingelheim and Re-Vana Therapeutics Announce Strategic Collaboration to Develop Long-Acting Ophthalmic Therapies

● Up to three development programs per year leading to a potential total deal value exceeding $1 billion contingent on milestone achievements. Ingelheim, Germany, Tampa, Florida, USA, and Belfast, Northern Ireland, UK [28 July 2025] – Boehringer Ingelheim and Re-Vana Therapeutics, a US and UK based developer of ocular therapeutics and ocular drug delivery technologies, today announced [...]

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibody Preclinical results demonstrate strong anti-tumor activity and favorable tolerability profile Phase 1 clinical trial evaluating ZW251 in hepatocellular carcinoma (HCC) expected to be initiated in 2025 VANCOUVER, British Columbia, July 28, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), [...]

Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents

Bangladesh Proposes to Ban Safer Nicotine Products Under Foreign Influence, Ignoring Public Health Evidence and Regional Precedents

MANILA, Philippines, July 28, 2025 (Korea Bizwire) – The Bangladesh Ministry of Health is pushing a new tobacco control bill that proposes a sweeping ban on all safer nicotine products (SNPs), including vaping devices and oral alternatives. Alarmingly, this move is being pursued without public consultation and under an interim government—raising serious concerns about transparency [...]

Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health

Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health

Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol LONDON, July 25, 2025 (Korea Bizwire) — Wellcome’s 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and [...]

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

Boehringer Laboratory Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic investments in R&D and global manufacturing to drive innovation and support future growth Boehringer Ingelheim, a leading research-driven biopharmaceutical company, reported positive [...]

Kalsec® Inc. Enhances and Rebrands Hops Division to KalHops

Kalsec® Inc. Enhances and Rebrands Hops Division to KalHops

Rebrand empowers brewers to “Brew Extraordinary™” with innovative and tailored hops offerings   KALAMAZOO, Mich., July 23, 2025 (Korea Bizwire) – Kalsec® Inc., a global natural ingredient solution provider for the food and beverage industry, today announced the relaunch of its hops division under the brand name KalHops. This strategic rebranding affirms Kalsec’s commitment to continued innovation [...]

Carestream Secures Partnership with Leading Distributor in Vietnam

Carestream Secures Partnership with Leading Distributor in Vietnam

ROCHESTER, N.Y., July 22, 2025 (Korea Bizwire) – Carestream Health recently secured an agreement with Vietnam South East Asia Joint Stock Company (VISTACOM), a leading distributor of advanced medical equipment solutions in Vietnam. “We are honored to join into a partnership with a renowned, industry leader like Carestream,” said Mr. Long Nguyen, Business Director of [...]

Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin

Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin

WASHINGTON, July 21, 2025 (Korea Bizwire) — Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and implementing immunization programs and strengthening health systems, joins the Sabin Vaccine Institute today as President of Global Immunization, assuming the reins of the nonprofit’s efforts in vaccination innovation and extending vaccine access. Martin [...]

Shadow Report Urges WHO FCTC to Embrace Tobacco Harm Reduction as a Core Strategy

Shadow Report Urges WHO FCTC to Embrace Tobacco Harm Reduction as a Core Strategy

MANILA, Philippines, July 21, 2025 (Korea Bizwire) – A newly revised Shadow Report, released by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), calls for a fundamental shift in the World Health Organization’s (WHO) approach to global tobacco control. The report criticizes the continued neglect of harm reduction under the WHO Framework Convention on [...]

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Company to participate in investor conferences in July and August VANCOUVER, British Columbia, July 17, 2025 (Korea Bizwire) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will [...]